NCT06018415 is a NA clinical trial of Early time-restricted eating (eTRE) in Metabolic Syndrome, sponsored by First Affiliated Hospital Xi'an Jiaotong University.

Who is sponsoring NCT06018415?

NCT06018415 is sponsored by First Affiliated Hospital Xi'an Jiaotong University.

What drugs are being tested in NCT06018415?

Interventions in NCT06018415: Early time-restricted eating (eTRE), Late time-restricted eating (lTRE).

What condition does NCT06018415 study?

NCT06018415 studies Metabolic Syndrome, Overweight and Obesity, Time Restricted Eating.

Is NCT06018415 still recruiting?

NCT06018415 is currently completed. Last updated 22 December 2025.

Last reviewed 2025-12-22 · How we verify

NCT06018415

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Early and Late Time-restricted Eating on Overweight Adults With Metabolic Syndrome

Completed NA Last updated 22 December 2025

What this trial tests

NA trial testing Early time-restricted eating (eTRE) in Metabolic Syndrome in 103 participants. Completed in 16 October 2024.

Timeline

7 May 2024

Primary endpoint
16 October 2024

16 October 2024

Quick facts

Lead sponsor	First Affiliated Hospital Xi'an Jiaotong University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	103
Start date	7 May 2024
Primary completion	16 October 2024
Estimated completion	16 October 2024
Sites	1 location across China

Drugs / interventions tested

Early time-restricted eating (eTRE)
Late time-restricted eating (lTRE)

Conditions studied

Metabolic Syndrome — all drugs for Metabolic Syndrome →
Overweight and Obesity — all drugs for Overweight and Obesity →
Time Restricted Eating — all drugs for Time Restricted Eating →

Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Who can join

Adults 18 to 65, any sex, with Metabolic Syndrome or Overweight and Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigators aim to compare the effects of early and late time-restricted feeding on overweight adults with metabolic syndrome

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

What are the effects of time-restricted eating upon metabolic health outcomes in individuals with metabolic syndrome: A scoping review.
Heath RJ, Welbourne J, Martin D. · · 2025 · cited 2× · PMID 40323226 · DOI 10.14814/phy2.70338

Verify or expand the search:

Other recruiting trials for Metabolic Syndrome

Currently open trials in the same condition.

NCT07501858 — Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metaboli · recruiting
NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting

Other First Affiliated Hospital Xi'an Jiaotong University trials

Trials by the same sponsor.

NCT07389460 — Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND) · Phase 3 · not yet recruiting
NCT07170176 — Effects of PFO Closure on Glymphatic Function and Clinical Symptoms in Patients With Migraine · NA · recruiting
NCT07168291 — Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma · EARLY_PHASE1 · not yet recruiting
NCT06775782 — Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke Due to Large Artery Atherosclerosis · NA · recruiting
NCT07266467 — Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Dis · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06018415 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital Xi'an Jiaotong University
Last refreshed: 22 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06018415.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing